Acrux (ASX:ACR)
ASX announcement history & article coverage
Transparent by design.
Announcments by Acrux (ASX:ACR) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Appendix 3Y Brooke
Appendix 3Y Warmbrunn
Appendix 3Y Oldham
Appendix 3Y Brumley
Appendix 3Y Dobinson
Application for quotation of securities - ACR
Application for quotation of securities - ACR
FY26 Appendix 4G and Corporate Governance Statement
FY26 Annual Report and Appendix 4E
Acrux FY26 revenue up 46%, net loss narrows 90%, advances Female Testosterone MDTS development
Acrux appoints Chief Medical Officer
Webinar invitation for 17 August 2026, 11am
Application for quotation of securities - ACR
Notification of cessation of securities - ACR
Investor Presentation - Female Testosterone for HSDD
Acrux presents Female Testosterone MDTS development and market opportunity at Bioshares Biotech Summit
Quarterly Activities/Appendix 4C Cash Flow Report
Acrux reports strong revenue growth, FDA Phase III pathway for Female Testosterone, and $1.6M funding
Cleansing Notice
Application for quotation of securities - ACR
Notification regarding unquoted securities - ACR
Appendix 3Y Dobinson
Application for quotation of securities - ACR
Results of Meeting
Application for quotation of securities - ACR
Notice of Extraordinary General Meeting/Proxy Form